Where is Innovation in Health Care heading?

By Holger Adelmann, DIA EMEA

Is Europe geared up to provide an infrastructure to nurture Biotechs? The European Biotechnology Enterprises (EBE) has done a very critical assessment! Is the Pharma sector still attractive for investors or is IT largely eating in? Do we need innovative funding models?

Read more …

Follow Holger on Twitter and LinkedIn for the latest articles